Timothy Rolph
CIK 1779479 · Chief Scientific Officer · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
47
Lifetime Open-Market Net
-$19.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Scientific Officer | 0 | $54.65 | $0 | -$19.56M | 47 | 2025-12-09 |
Recent Filings · Page 3 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-30 | Akero Therapeutics, Inc. (AKRO) Delisted | Gift (G) | −14,100 | $0 | EDGAR |
| 2024-12-18 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | +20,000 | -$42.7K | EDGAR |
| 2024-12-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −2,368 | -$100.3K | EDGAR |
| 2024-09-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −537 | -$14.1K | EDGAR |
| 2024-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +1,064 | $21.2K | EDGAR |
| 2024-06-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,380 | -$53.9K | EDGAR |
| 2024-03-15 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −619 | -$17.5K | EDGAR |
| 2023-12-18 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −514 | -$10.7K | EDGAR |
| 2023-12-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +32,497 | $0 | EDGAR |
| 2023-09-25 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −531 | -$26.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.